Veloxis Pharmaceuticals www.veloxis.com

2.0

Unique link for this page:

https://sitemorse.com/sa/218587/1/124d050b

Purchase the detailed results View Priorities (FREE)

INDEX	Rank	First	Last	Climber	Faller
2018 Q2	216th	Cytogen	Perrigo UK	Sanofi (+175)	Advaxis (-106)
2018 Q1	216th	HG Capital Trust	Perrigo UK	Genus (+153)	Sawai Pharmaceutical (-131)
2017 Q4	214th	HG Capital Trust	Cerus	Zandu (+104)	Aptalis Pharma (-101)
2017 Q3	181st	Servier UK	Perrigo UK	Leo Pharma UK (+86)	Chiesi (-125)
2017 Q2	190th	Servier UK	Myriad Genetics	Bosnalijek (+196)	Anika Therapeutics (-175)
2017 Q1	192nd	Servier UK	Sinovac Biotech	Regeneron (+130)	Bosnalijek (-112)
2016 Q4	122nd	Taisho Pharmaceutical	Sinovac Biotech	MannKind Corporation (+172)	CinnaGen (-201)
2016 Q3	126th	Wockhardt	Sinovac Biotech	Biota (+134)	Daiichi-Sankyo UK (-98)
2016 Q2	128th	ProStrakan Group	Santen Europe	Julphar (+185)	Alfa Wassermann (-131)
2016 Q1	222nd	Neurocrine Biosciences	Enzon Pharmaceuticals	Cipla (+157)	Laboratoires Thea (-127)
2015 Q4	234th	Anika Therapeutics	Sinopharm	Baxter International (+168)	ImmunoGen (-123)
2015 Q3	230th	Anika Therapeutics	Beximco Pharmaceuticals	Dr Reddy's (+150)	Progenics Pharmaceuticals (-75)
2015 Q2	221st	Actelion	Sinopharm	Anika Therapeutics (+187)	Mylan (-157)
2015 Q1	235th	Biogen Idec	Sinopharm	NPS Pharmaceuticals (+133)	Hospira UK (-149)
2014 Q4	226th	Biogen Idec	Sinopharm	Bial Portela (+117)	Genus (-124)
2014 Q3	216th	Biogen Idec	Sinopharm	Mitsubishi Tanabe Pharma Europe Ltd (+207)	Questcor (-210)
2014 Q2	220th	Cytogen	Merck Sharp & Dohme, MSD	Medivation (+122)	Idenix Pharmaceuticals (-222)
2014 Q1	231st	Idenix Pharmaceuticals	Sinopharm	Advaxis (+167)	Celgene (-114)
2013 Q4	225th	Idenix Pharmaceuticals	Sinopharm	Intas Biopharmaceuticals (+132)	Sawai Pharmaceutical (-160)
2013 Q3	165th	Idenix Pharmaceuticals	Sinopharm	ImmunoGen (+164)	ARIAD Pharmaceuticals (-140)
2013 Q2	131st	Galenica AG	Sinopharm	Ferozsons Laboratories (+54)	Hospira (-180)
2013 Q1	133rd	Siegfried AG	Sinopharm Group	Perrigo (+82)	Alkaloid (-77)
2012 Q4	135th	NovImmune	Sinopharm Group	Takeda Pharma AG (+125)	Ego Pharmaceuticals (-116)
2012 Q3	122nd	NovImmune	Sinopharm Group	GenKyoTex SA (+147)	Genzyme (-90)
2012 Q2	105th	Cilag AG	Sinopharm Group	LEO Pharmaceutical Products Sarath Ltd. (+122)	Sanofi-Aventis (-116)
2012 Q1	135th	Cilag AG	Sinopharm Group	Wockhardt (+196)	Johnson & Johnson Pharmaceutical Research & Development (-90)
2011 Q4	138th	Anergis	Sinopharm Group	Schwabe Pharma AG (+93)	Nitec Pharma AG (-120)